Sign up to save your podcasts
Or
Share 323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
View all episodes
By STAT
4.5
309309 ratings
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
More shows like The Readout Loud
View all
Planet Money
30,678 Listeners
Odd Lots
1,896 Listeners
What the Health? From KFF Health News
499 Listeners
The Indicator from Planet Money
9,513 Listeners
The Journal.
6,086 Listeners
Tradeoffs
394 Listeners
Biotech 2050 Podcast
61 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
34 Listeners
Dwarkesh Podcast
505 Listeners
Hard Fork
5,473 Listeners
Biotech Hangout
19 Listeners
Ground Truths
48 Listeners
Money Stuff: The Podcast
387 Listeners
The BioCentury Show
12 Listeners